Novartis (NVS) has agreed to acquire Regulus Therapeutics (RGLS) for an initial payment of $7.00 per share in cash at closing, or $800 million, Regulus said Wednesday.
Shares of Regulus more than doubled as intraday trading volume soared to over 23.4 million from a daily average of about 1.3 million.
Oddity Tech (ODD) reported Q1 adjusted earnings and sales late Tuesday above forecasts and raised its full-year EPS and revenue guidance.
Shares soared 26% as intraday trading volume surged to more than 4.2 million from a daily average of about 458,000.
Jeffs' Brands (JFBR) said Wednesday that it signed a definitive agreement to sell its Smart Repair Pro unit and its 49.1% stake in SciSparc Nutraceuticals to Plantify Foods.
Shares jumped 52% as intraday trading volume catapulted to over 85.8 million compared with a daily average of about 317,000.
Price: 113.49, Change: +0.04, Percent Change: +0.04
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。